Tea in Health and Disease
Tea, made from the leaves of the Camellia senenisis plant, is the second most consumed beverage worldwide after water. Accumulating evidence from cellular, animal, epidemiological and clinical studies have linked tea consumption to various health benefits, such as chemoprevention of cancers, chronic...
Saved in:
: | |
---|---|
Year of Publication: | 2019 |
Language: | English |
Physical Description: | 1 electronic resource (222 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 03700nam-a2201045z--4500 | ||
---|---|---|---|
001 | 993548069204498 | ||
005 | 20231214133347.0 | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 202102s2019 xx |||||o ||| 0|eng d | ||
020 | |a 3-03897-987-2 | ||
035 | |a (CKB)4920000000094827 | ||
035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/60503 | ||
035 | |a (EXLCZ)994920000000094827 | ||
041 | 0 | |a eng | |
100 | 1 | |a Dou, Q. Ping |4 auth | |
245 | 1 | 0 | |a Tea in Health and Disease |
260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2019 | ||
300 | |a 1 electronic resource (222 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
520 | |a Tea, made from the leaves of the Camellia senenisis plant, is the second most consumed beverage worldwide after water. Accumulating evidence from cellular, animal, epidemiological and clinical studies have linked tea consumption to various health benefits, such as chemoprevention of cancers, chronic inflammation, heart and liver diseases, diabetes, neurodegenerative diseases, etc. Although such health benefits have not been consistently observed in some intervention trials, positive results from clinical trials have provided direct evidence supporting the cancer-protective effect of green tea. In addition, numerous mechanisms of action have been suggested to contribute to tea’s disease-preventive effects. Furthermore, effects of the processing and storage of tea, as well as additives on tea’s properties have been investigated. | ||
546 | |a English | ||
653 | |a polyphenols | ||
653 | |a cell cycle arrest and apoptosis | ||
653 | |a neuroblastoma | ||
653 | |a salivary ?-amylase activity | ||
653 | |a cancer apoptosis | ||
653 | |a yaupon holly | ||
653 | |a bioaccessibility | ||
653 | |a fracture | ||
653 | |a p53 | ||
653 | |a tea | ||
653 | |a Liubao tea | ||
653 | |a BE(2)-C | ||
653 | |a matrix metalloproteinase-1 (MMP-1) | ||
653 | |a catechin | ||
653 | |a renal stone | ||
653 | |a oxalate | ||
653 | |a protein expression | ||
653 | |a 67LR | ||
653 | |a Alzheimer's disease | ||
653 | |a EGCG | ||
653 | |a nutraceutical | ||
653 | |a diseases | ||
653 | |a anti-oxidant | ||
653 | |a heme oxygenase-1 | ||
653 | |a polyphenol | ||
653 | |a anxiety | ||
653 | |a matcha | ||
653 | |a ERCC1/XPF | ||
653 | |a neuro-sphere | ||
653 | |a tea consumption | ||
653 | |a theanine | ||
653 | |a Rosmarinic acid | ||
653 | |a yerba mate | ||
653 | |a hypercalciuria | ||
653 | |a gene expression | ||
653 | |a microbiota | ||
653 | |a cohort study | ||
653 | |a histone deacetylase 2 (HDAC2) | ||
653 | |a guayusa | ||
653 | |a nuclear factor erythroid 2-related factor 2 (Nrf2) | ||
653 | |a DNA repair | ||
653 | |a mRNA expression | ||
653 | |a caffeine | ||
653 | |a chemoprevention | ||
653 | |a cisplatin | ||
653 | |a 6-OH-11-O-hydroxyphenanthrene | ||
653 | |a adrenal hypertrophy | ||
653 | |a hepatic damage | ||
653 | |a anti-photoaging | ||
653 | |a cell death | ||
653 | |a green tea | ||
653 | |a kudingcha | ||
653 | |a suberoylanilide hydroxamic acid (SAHA) | ||
653 | |a epigallocatechin gallate (EGCG) | ||
653 | |a stress-reduction | ||
653 | |a calcium oxalate monohydrate | ||
653 | |a Camellia sinensis | ||
653 | |a chemoresistance | ||
653 | |a tea polyphenols | ||
653 | |a green tea polyphenols | ||
653 | |a green tea catechins | ||
653 | |a N-MYC | ||
653 | |a cancer | ||
653 | |a epigallocatechin-gallate (EGCG) | ||
653 | |a Parkinson's disease | ||
776 | |z 3-03897-986-4 | ||
906 | |a BOOK | ||
ADM | |b 2023-12-15 05:51:29 Europe/Vienna |f system |c marc21 |a 2019-11-10 04:18:40 Europe/Vienna |g false | ||
AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338723310004498&Force_direct=true |Z 5338723310004498 |b Available |8 5338723310004498 |